Literature DB >> 12478298

Signal-dependent regulation of splicing via phosphorylation of Sam68.

Nathalie Matter1, Peter Herrlich, Harald König.   

Abstract

Evolution of human organismal complexity from a relatively small number of genes--only approximately twice that of worm or fly--is explained mainly by mechanisms generating multiple proteins from a single gene, the most prevalent of which is alternative pre-messenger-RNA splicing. Appropriate spatial and temporal generation of splice variants demands that alternative splicing be subject to extensive regulation, similar to transcriptional control. Activation by extracellular cues of several cellular signalling pathways can indeed regulate alternative splicing. Here we address the link between signal transduction and splice regulation. We show that the nuclear RNA-binding protein Sam68 is a new extracellular signal-regulated kinase (ERK) target. It binds exonic splice-regulatory elements of an alternatively spliced exon that is physiologically regulated by the Ras signalling pathway, namely exon v5 of CD44. Forced expression of Sam68 enhanced ERK-mediated inclusion of the v5-exon sequence in mRNA. This enhancement was impaired by mutation of ERK-phosphorylation sites in Sam68, whereas ERK phosphorylation of Sam68 stimulated splicing of the v5 exon in vitro. Finally, Ras-pathway-induced alternative splicing of the endogenous CD44-v5 exon was abolished by suppression of Sam68 expression. Our data define Sam68 as a prototype regulator of alternative splicing whose function depends on protein modification in response to extracellular cues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12478298     DOI: 10.1038/nature01153

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  192 in total

1.  Transient recruitment of the hnRNP K protein to inducibly transcribed gene loci.

Authors:  Jerzy Ostrowski; Yasunobu Kawata; Daniel S Schullery; Oleg N Denisenko; Karol Bomsztyk
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

2.  A novel function for Sam68: enhancement of HIV-1 RNA 3' end processing.

Authors:  Meredith McLaren; Kengo Asai; Alan Cochrane
Journal:  RNA       Date:  2004-07       Impact factor: 4.942

Review 3.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

Review 4.  Comparing peripheral glial cell differentiation in Drosophila and vertebrates.

Authors:  Floriano Rodrigues; Imke Schmidt; Christian Klämbt
Journal:  Cell Mol Life Sci       Date:  2010-09-04       Impact factor: 9.261

Review 5.  Transcription and post-transcriptional regulation of spermatogenesis.

Authors:  Anilkumar Bettegowda; Miles F Wilkinson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

6.  Differential effects of PKA-controlled CaMKK2 variants on neuronal differentiation.

Authors:  Wenguang Cao; Muhammad Sohail; Guodong Liu; Geremy A Koumbadinga; Vincent G Lobo; Jiuyong Xie
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

7.  Differential regulation of fibrinogen γ chain splice isoforms by interleukin-6.

Authors:  Chantelle M Rein-Smith; Nathan W Anderson; David H Farrell
Journal:  Thromb Res       Date:  2012-10-01       Impact factor: 3.944

8.  RNA-binding protein Sam68 controls synapse number and local β-actin mRNA metabolism in dendrites.

Authors:  Matthew E Klein; Thomas J Younts; Pablo E Castillo; Bryen A Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  High Sam68 expression predicts poor prognosis in non-small cell lung cancer.

Authors:  Z Zhang; Y Xu; N Sun; M Zhang; J Xie; Z Jiang
Journal:  Clin Transl Oncol       Date:  2014-02-13       Impact factor: 3.405

Review 10.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.